Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

NCT03460743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1556

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: Study group - quadrivalent recombinant hemagglutinin influenza vaccine
BIOLOGICAL: Control group - quadrivalent inactivated influenza vaccine

Sponsor

Laboratorios Liomont

Collaborators

[object Object]
[object Object]
[object Object]